|
|
|
15.08.25 - 08:06
|
Polymer Factory Sweden (publ) Interim report Q2 2025 (Cision)
|
|
|
Second quarter, April-June 2025
· Earnings increased by 87% during the quarter compared to Q2 2024
· Polymer Factory announces a substantial order of SpheriCal® products
· The company signed a Supply Agreement with Global Leader in Scientific Instrumentation
· Polymer Factory Receives Order from International Energy Company
· Bruker launches QSee™ in partnership with Polymer Factory
Comments from CEO Mats Wallnér
During the second quarter of 2025, we saw improved financial balance in the company – revenues increased significantly while costs were reduced. This is a sign of...
|
|
|
|
|
12.08.25 - 13:06
|
Bruker Announces Quarterly Dividend (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock. The dividend will be paid on October 3, 2025 to stockholders of record as of September 23, 2025.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis...
|
|
|
|
|
|
|
|
|
|
|
04.08.25 - 16:00
|
Bruker (BRKR) Misses Q2 Earnings Estimates (Zacks)
|
|
|
Bruker (BRKR) delivered earnings and revenue surprises of -3.03% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|
|
|
|
|
04.08.25 - 13:06
|
Bruker Reports Second Quarter 2025 Financial Results (Business Wire)
|
|
|
Q2 2025 revenues of $797.4 million, down 0.4% year-over-year (yoy); organic revenue down 7.0%, and constant-exchange rate (CER) revenue down 3.3%
Q2 2025 GAAP diluted EPS $0.05; non-GAAP diluted EPS $0.32
Announcing a significantly expanded cost savings initiative expected to reduce annual costs by $100 - $120 million in FY 2026
Recent additional key innovations for profitable growth acceleration in post-genomic disease biology research and next-gen drug discovery and development:
timsOmni: ushers in era of functional proteomics and proteoform analysis - at depth
timsMetabo: unprecedented annotation confidence in 4D metabolomics - with ultra-high sensitivity at speed and scale
timsUltra AIP: ultra-high sensitivity 4D single-cell proteomics and immunopeptidomics
Biocrates acquisition expands Bruker multiomics solutions with unique consumables, software and specialty CRO services for quantitative metabolomics
Updated FY2025 guidance:
Revenue $3.43 to $3.50 billion, with reported growth of 2% to 4% yoy, CER ...
|
|
|
|
|
|
|
21.07.25 - 14:06
|
Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025 (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million, which implies approximately flat reported revenue year-over-year. Bruker estimates that its non-GAAP organic revenue in the second quarter of 2025 declined approximately 7% year-over-year, with constant-exchange rate revenue declining approximately 3%.
Second quarter 2025 bookings reflect weak academic demand, as well as softness in the U.S. biopharma market. Second quarter 2025 non-GAAP EPS is expected in the $0.32 - $0.34 range, representing approximately a $0.19 per share decline year-over-year, including a $0.06 foreign currency headwind.
Bruker plans to host its earnings conference call and webcast on Monday, August 4, 2025 at 8:30 a.m. EDT to discuss second quarter 2025 financial results, business developments and on-going cost actions.
Second Quarter 2025 Earnings Conference Call and Webcast
To listen to t...
|
|
|
|
|
|
|
|
|
|
|
|
|
03.06.25 - 13:03
|
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics (Business Wire)
|
|
|
Acquisition further expands Bruker's multiomics strategy with biocrates metabolomics kits and assays, and related software and research servicesINNSBRUCK, Austria--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed.
biocrates is a global leader in mass spectrometry (MS)-based quantitative metabolite and lipid analysis kits, assays, software and services that make standardized metabolomics accessible to laboratories worldwide. The biocrates kits cover over 1,000+ metabolites from more than 40 metabolite classes, and the biocrates metabolomics technology platform combines innovative sample preparation, metabolite identification, and data analysis.
The acquisition of biocrates further enhances Bruker's MS-based metabolomics solutions. It also supports Bruker's expansion into multiomics solutions, including instruments, reagents, software, and research services, buil...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
